Treatment Options for Non-Small Cell Lung Cancer Harboring Uncommon *EGFR* Mutations by Alfredo Addeo

Get full text

Intrathecal Methotrexate and Craniospinal Radiotherapy Can Be an Effective Treatment of Carcinomatous Meningitis in Patients with Breast Cancer: Case Reports by Magdalena Meissner, Alfredo Addeo

Get full text

Editorial: Insights in thoracic oncology: 2021/2022 by Kaushal Parikh, Alfredo Addeo

Get full text

Age is a fact and not an exclusion criterion in EGFR treatment by Alex Friedlaender, Alfredo Addeo

Get full text

Treatment with Ipilimumab: A Case Report of Complete Response in a Metastatic Malignant Melanoma Patient by Alfredo Addeo, Ciro Roberto Rinaldi

Get full text

The Landscape of Immunotherapy Resistance in NSCLC by Daniele Frisone, Alex Friedlaender, Alex Friedlaender, Alfredo Addeo, Alfredo Addeo, Petros Tsantoulis, Petros Tsantoulis

Get full text

Evolving Therapeutic Scenario of Stage III Non-Small-Cell Lung Cancer by Nathalie Baudoux, Alex Friedlaender, Alfredo Addeo

Get full text

KRAS G12C Mutations in NSCLC: From Target to Resistance by Alfredo Addeo, Giuseppe Luigi Banna, Alex Friedlaender

Get full text

Gender-specific aspects of epidemiology, molecular genetics and outcome: lung cancer by Solange Peters, Alex Friedlaender, Alfredo Addeo, Nuria Mederos

Get full text

Pleural Mesothelioma in the Era of Immunotherapy by Mathieu Chevallier, Floryane Kim, Alex Friedlaender, Alfredo Addeo

Get full text

Management of stage III non-small-cell lung cancer: rays of hope by Floryane Kim, Maxime Borgeaud, Alfredo Addeo, Alex Friedlaender

Get full text

Reply to Authors by Alex Friedlaender, Alfredo Addeo, Giuseppe Banna, Alessandra Curioni-Fontecedro

Get full text

Vertebral Metastasis Treated by Vertebroplasty, a Cause of Respiratory Failure: Case Report and Literature Review by Mathieu Chevallier, Chloé Chevallier-Lugon, Alex Friedlaender, Alfredo Addeo

Get full text

Next Generation Sequencing and Genetic Alterations in Squamous Cell Lung Carcinoma: Where Are We Today? by Alex Friedlaender, Giuseppe Banna, Umberto Malapelle, Pasquale Pisapia, Alfredo Addeo

Get full text

First-Line Treatment for Advanced SCLC: What Is Left Behind and Beyond Chemoimmunotherapy by Emilio Francesco Giunta, Alfredo Addeo, Alessio Rizzo, Giuseppe Luigi Banna

Get full text

Immune checkpoint inhibitor-induced aseptic meningitis and encephalitis: a case-series and narrative review by Laure Thouvenin, Timothée Olivier, Giuseppe Banna, Alfredo Addeo, Alex Friedlaender

Get full text

Chemotherapy in Combination With Immune Checkpoint Inhibitors for the First-Line Treatment of Patients With Advanced Non-small Cell Lung Cancer: A Systematic Review and Literature-... by Alfredo Addeo, Giuseppe Luigi Banna, Giulio Metro, Massimo Di Maio

Get full text

Oncogenic alterations in advanced NSCLC: a molecular super-highway by Alex Friedlaender, Maurice Perol, Giuseppe Luigi Banna, Kaushal Parikh, Alfredo Addeo

Get full text

The Impact of Variant Allele Frequency in EGFR Mutated NSCLC Patients on Targeted Therapy by Alex Friedlaender, Petros Tsantoulis, Mathieu Chevallier, Claudio De Vito, Alfredo Addeo

Get full text

The Evolving Role of Immune-Checkpoint Inhibitors in Malignant Pleural Mesothelioma by Maxime Borgeaud, Floryane Kim, Alex Friedlaender, Filippo Lococo, Alfredo Addeo, Fabrizio Minervini

Get full text